115 related articles for article (PubMed ID: 12047416)
1. In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey.
Kocagöz S; Akova M; Altun B; Gür D; Hasçelik G
Clin Microbiol Infect; 2002 Apr; 8(4):240-2. PubMed ID: 12047416
[TBL] [Abstract][Full Text] [Related]
2. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of six new fluoroquinolones against Brucella melitensis.
Trujillano-Martín I; García-Sánchez E; Martínez IM; Fresnadillo MJ; García-Sánchez JE; García-Rodríguez JA
Antimicrob Agents Chemother; 1999 Jan; 43(1):194-5. PubMed ID: 9869594
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.
Yamazhan T; Aydemir S; Tünger A; Serter D; Gökengin D
Med Princ Pract; 2005; 14(6):413-6. PubMed ID: 16220015
[TBL] [Abstract][Full Text] [Related]
6. Activity of BAY y 3118, a novel 4-quinolone, against Brucella melitensis.
García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo MJ
J Chemother; 1994 Apr; 6(2):102-6. PubMed ID: 8077983
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
Kilic S; Dizbay M; Cabadak H
J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
[TBL] [Abstract][Full Text] [Related]
8. Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones.
García-Rodríguez JA; García Sánchez JE; Trujillano I; García Sánchez E; García García MI; Fresnadillo MJ
Antimicrob Agents Chemother; 1995 May; 39(5):1194-5. PubMed ID: 7625815
[TBL] [Abstract][Full Text] [Related]
9. In vitro drug resistance of clinical isolated Brucella against antimicrobial agents.
Xu XL; Chen X; Yang PH; Liu JY; Hao XK
Asian Pac J Trop Med; 2013 Nov; 6(11):921-4. PubMed ID: 24083592
[TBL] [Abstract][Full Text] [Related]
10. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
[TBL] [Abstract][Full Text] [Related]
11. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Salmonella typhi and Brucella melitensis to the new fluoroquinolone rufloxacin (MF 934).
Qadri SM; Ayub A; Ueno Y; Saldin H
Chemotherapy; 1993; 39(5):311-4. PubMed ID: 8396527
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey.
Sayan M; Kılıc S; Uyanık MH
J Infect Chemother; 2012 Feb; 18(1):41-6. PubMed ID: 21826587
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.
Khan MY; Dizon M; Kiel FW
Antimicrob Agents Chemother; 1989 Aug; 33(8):1409-10. PubMed ID: 2802568
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
16. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
Qadri SM; Ueno Y; Ayub A
Chemotherapy; 1993; 39(6):386-9. PubMed ID: 8222864
[TBL] [Abstract][Full Text] [Related]
17. In vitro antimicrobial susceptibility of Brucella species.
Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Brucella melitensis to fluoroquinolones.
Qadri SM; Akhtar M; Ueno Y; al-Sibai MB
Drugs Exp Clin Res; 1989; 15(10):483-5. PubMed ID: 2632216
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
Naber KG; Hollauer K; Kirchbauer D; Witte W
Int J Antimicrob Agents; 2000 Nov; 16(3):239-43. PubMed ID: 11091042
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
